INCHEON, South Korea, Aug. 4, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) today held an online ceremony to announce the launch of its proprietary cell line technology, S-CHOice. S-CHOice builds on glutamine synthase (GS) knock-out Chinese hamster ovary (CHO) cell line...
from PR Newswire: https://ift.tt/39UM5oo
No comments:
Post a Comment